Notably, food had relatively limited impact on brensocatib absorption, enhancing clinical application convenience ( These early clinical studies successfully established brensocatibs safe dose range and pharmacodynamic characteristics, providing solid foundations for subsequent Phase II clinical trial design and implementation
, The current literature suggests that activation of these receptor complexes influences pathways involved in food intake regulation, gastric physiology, and energy balance
The framing throughout is research literature observation, not therapeutic recommendation
Nausea and Dizziness : Transient nausea affects 5 to 10% of reported cases, with occasional lightheadedness reported in 3 to 7% during the first week of administration
Improved mood and memory Although several studies show a link between depression and low B12 levels, there's no evidence that increasing the levels of B12 can help ease depression symptoms